243 related articles for article (PubMed ID: 12617766)
1. Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters.
Massicotte J; Viens A; Yao MH; Leonardi A; Sironi G; Wang H; Dumont L
Acta Pharmacol Sin; 2003 Mar; 24(3):199-206. PubMed ID: 12617766
[TBL] [Abstract][Full Text] [Related]
2. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster.
Villame J; Massicotte J; Jasmin G; Dumont L
Cardiovasc Drugs Ther; 2001 Jan; 15(1):41-8. PubMed ID: 11504162
[TBL] [Abstract][Full Text] [Related]
3. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
[TBL] [Abstract][Full Text] [Related]
4. Reactivity to endothelium-dependent and -independent vasoactive substances is maintained in coronary resistance vessels of the failing hamster heart.
Véronneau M; Tanguay M; Fontaine E; Jasmin G; Dumont L
Cardiovasc Res; 1997 Mar; 33(3):623-30. PubMed ID: 9093532
[TBL] [Abstract][Full Text] [Related]
5. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone analog, diiodothyropropionic acid (DITPA), exerts beneficial effects on chamber and cellular remodeling in cardiomyopathic hamsters.
Kuzman JA; Tang Y; Vogelsang KA; Said S; Anderson BE; Morkin E; Gerdes AM
Can J Physiol Pharmacol; 2007; 85(3-4):311-8. PubMed ID: 17612639
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters.
Crespo MJ; De Mello WC
Eur J Pharmacol; 2001 May; 420(2-3):133-41. PubMed ID: 11408035
[TBL] [Abstract][Full Text] [Related]
9. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cardiac SR Ca(2+)-release channels during development of heart failure in cardiomyopathic hamsters.
Ueyama T; Ohkusa T; Hisamatsu Y; Nakamura Y; Yamamoto T; Yano M; Matsuzaki M
Am J Physiol; 1998 Jan; 274(1):H1-7. PubMed ID: 9458845
[TBL] [Abstract][Full Text] [Related]
11. Capillary density and leukocyte adhesion in hamsters with hereditary cardiomyopathy.
Colantuoni A; Coppini G; Bertuglia S
Microvasc Res; 1998 Sep; 56(2):85-94. PubMed ID: 9756731
[TBL] [Abstract][Full Text] [Related]
12. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle.
Vargiu R; Littarru GP; Fraschini M; Perinu A; Tiano L; Capra A; Mancinelli R
Biofactors; 2010; 36(3):229-39. PubMed ID: 20533397
[TBL] [Abstract][Full Text] [Related]
14. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters.
Masunaga R; Nagasaka A; Sawai Y; Hayakawa N; Nakai A; Hotta K; Kato Y; Hishida H; Takahashi H; Naka M; Shimada Y; Tanaka T; Hidaka H; Itoh M
J Mol Cell Cardiol; 2004 Sep; 37(3):767-74. PubMed ID: 15350849
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster.
Popov D; Costache G; Georgescu A; Enache M
Cell Tissue Res; 2002 Apr; 308(1):109-20. PubMed ID: 12012211
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological properties of lipophilic calcium antagonists.
van Zwieten PA
Blood Press Suppl; 1998; 2():5-9. PubMed ID: 9850436
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress.
Escobales N; Crespo MJ
Vascul Pharmacol; 2006 Jan; 44(1):22-8. PubMed ID: 16301003
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure.
Okuda N; Hayashi T; Mori T; Inamoto S; Okabe M; Mieno S; Horimoto H; Kitaura Y
Hypertens Res; 2005 May; 28(5):431-8. PubMed ID: 16156507
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of 3 combinations of enalapril, metoprolol, and spironolactone on cardiac remodeling in dilated cardiomyopathic hamsters.
Laviolle B; Pape D; Turlin B; Bellissant E
J Card Fail; 2006 Dec; 12(9):752-8. PubMed ID: 17174238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
